47 results on '"Kukreti, Vishal"'
Search Results
2. Recovery of a quality improvement project during the COVID pandemic.
3. Implementation and impact of Choosing Wisely recommendations in oncology: A scoping review.
4. Clinical utility of interim CT scans in patients receiving bendamustine and rituximab for first line treatment of follicular lymphoma.
5. Evolving Best Practice for Take-Home Cancer Drugs
6. Improving medication reconciliation in ambulatory cancer care.
7. Current state assessment of the organization and delivery of systemic treatment in Ontario.
8. Evaluation of Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnosis Clinic
9. Medication reconciliation practices in ambulatory cancer care across Canada.
10. Developing a standardized approach to cancer medication-related infusion reaction prevention and management in Ontario.
11. Predicting acute care use following the initiation of systemic therapy for solid tumors.
12. Evolving best practice for take-home cancer drugs in Ontario.
13. Improving the Safety and Quality of Systemic Treatment Regimens in Computerized Prescriber Order Entry Systems
14. Predicting acute care use following initiation of systemic therapy for solid tumors.
15. Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study
16. Establishing best practice recommendations for systemic treatment regimen development and maintenance.
17. Understanding the financial impact of beyond use date in a publicly funded cancer system.
18. Reviewing systemic treatment regimens to reduce unintentional errors.
19. Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone (KPd) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): A Multiple Myeloma Research Consortium multicenter study.
20. Feasibility, acceptability, and efficacy of a proactive telephone intervention to improve toxicity management during chemotherapy.
21. Meeting patient and provider eTechnology needs: A provincial approach.
22. A retrospective analysis of upfront tandem autologous stem cell transplantation (ASCT) for high-risk (HR) myeloma (MM) patients (Pts).
23. Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
24. Automating a program for the evidence-based reimbursement of oncology drugs across a complex network: Benefits and challenges.
25. Understanding the interaction between physicians and pharmacists as a method of quality improvement.
26. A strategic roadmap for oncology electronic medical records (EMRs) in Ontario’s complex multiregional health care system.
27. Evaluating the implementation of computerized prescriber order entry (CPOE) for systemic treatment (ST) in Ontario.
28. Moving to secondary use of IT solutions: A provincial “near miss indicator” for chemotherapy.
29. Enhancing the delivery of take-home cancer therapies in Ontario.
30. A phase 1 dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with heavily pretreated non-Hodgkin lymphoma (NHL).
31. A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas.
32. Treatment of relapsed/refractory multiple myeloma with weekly cyclophosphamide plus bortezomib plus prednisone or dexamethasone (CyBor-P/D): Updated experience at Princess Margaret Cancer Centre (PMCC).
33. The Ontario oncology electronic medical record (EMR): The integration of end user and provincial needs.
34. Use of pharmacist integration in oncology clinics to identify and resolve moderate to major drug-drug interactions.
35. Concordance with best-practice guidelines for systemic treatment computerized prescriber order entry systems.
36. Prolonged therapy with single-agent bortezomib (btz) in four patients (pts) with relapsed primary systemic AL amyloidosis treated in the CAN2007 phase II study.
37. How to integrate vital interdisciplinary information in a non-closed-loop system?
38. From evidence to impact: Determining the vital few indicators for systemic treatment computerized prescriber order entry systems (ST CPOE).
39. Combining web-based educational tools and mobile apps.
40. Quality of adjuvant chemotherapy in stage III colon cancer.
41. Safe chemotherapy: Clinicians driving technology and not the other way around.
42. Bridging efforts to longitudinally improve and evaluate venous thromboembolism prophylaxis uptake in hospitalized cancer patients through interprofessional teamwork (BELIEVE IT): A study by Princess Margaret Cancer Centre.
43. Tale of Two Lymphomas: Peripheral T-Cell Lymphoma After Allogeneic Stem-Cell Transplantation for Marginal Zone Lymphoma
44. Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
45. Spontaneous Remission in a Patient With t(4;14) Translocation Multiple Myeloma
46. Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone in Relapsed and Refractory Multiple Myeloma
47. Small Intestinal B-Cell Lymphoma in a Patient With Lymphangiectasia Secondary to Abdominal Lymphangioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.